Introduction of new NHS vaccination programmes against respiratory syncytial virus (RSV)

Following guidance from the Joint Committee on Vaccination and Immunisation (JCVI), we are writing to systems to set out next steps for delivery of 2 new respiratory syncytial virus (RSV) vaccination programmes from 1 September 2024, for older adults and during pregnancy for infant protection.

RSV is a common respiratory virus that that can cause serious lung infections. While RSV infection can occur at any age, the risk and severity of RSV and its complications are increased in older adults and in neonates and small babies, and it has a considerable impact on individuals and NHS services during the winter months.

Following successful completion of a competitive tender and with funding approved from the Department of Health and Social Care (DHSC), we are pleased to be able to provide further information about the programme. We ask that you share this with all local partners involved in commissioning and delivering the programme.

For further information please click on the following link: Introduction of new NHS vaccination programmes against respiratory syncytial virus (RSV) – GOV.UK (www.gov.uk)